JMN Financial’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding HRTX
JMN Financial's HRTX Position: Q3 2026 in Review
JMN Financial sold out of Heron Therapeutics (HRTX) in Q3 2026, closing a stake of 11,269 shares — an estimated $4.81K sold.
JMN Financial first reported a position in HRTX in Q2 2026 and held it in 1 quarter. The position peaked at $4.81K in Q2 2026. 159 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.
- JMN Financial reported no remaining Heron Therapeutics position as of Q3 2026 after selling out during the quarter.
- JMN Financial sold 11,269 Heron Therapeutics shares in Q3 2026, an estimated $4.81K.
- JMN Financial first reported a position in Heron Therapeutics in Q2 2026 and held it in 1 quarter.
- JMN Financial's Heron Therapeutics position peaked at $4.81K in Q2 2026.
- 159 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.
Based on JMN Financial's 13F filing for Q3 2026, filed 10 Nov 2026.